CASI Pharmaceuticals Inc. (CASI)
NASDAQ: CASI
· Real-Time Price · USD
2.35
0.41 (21.13%)
At close: Aug 15, 2025, 3:59 PM
2.00
-14.89%
After-hours: Aug 15, 2025, 07:47 PM EDT
CASI Pharmaceuticals Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 31.37M | 28.54M | 21.27M | 22.32M | 28.16M | 33.1M | 42.26M | 43.64M | 42.39M | 43.11M | 37.01M | 34.91M | 33.49M | 30.17M | 25.83M | 21.96M | 17.47M |
Cost of Revenue | 18.41M | 17.39M | 9.54M | 9.44M | 11.51M | 13.28M | 15.28M | 15.88M | 15.45M | 15.83M | 15.36M | 14.53M | 13.96M | 12.56M | 10.71M | 9.12M | 8.65M |
Gross Profit | 12.96M | 11.15M | 11.74M | 12.88M | 16.65M | 19.81M | 26.98M | 27.76M | 26.95M | 27.28M | 21.65M | 20.38M | 19.54M | 17.61M | 15.12M | 12.84M | 8.82M |
Operating Income | -40.55M | -39.39M | -36.67M | -33.3M | -33.85M | -31.85M | -10.01M | -11.26M | -9.66M | -9.74M | -32.76M | -33.3M | -33.53M | -41.84M | -45.67M | -57.44M | -58.35M |
Interest Income | 77K | 131K | 644K | 805K | 944K | 1.01M | 528K | 380K | 281K | 153K | 187K | 253K | 289K | 321K | 352K | 705K | 782K |
Pretax Income | -39.29M | -38.07M | -29.15M | -26.32M | -29.41M | -25.7M | -36.84M | -37.41M | -34.84M | -37.43M | -26.31M | -31.31M | -30.56M | -35.84M | -44.47M | -51.21M | -52.96M |
Net Income | -40.48M | -39.26M | -30.35M | -26.59M | -29.86M | -26.34M | -39.38M | -38.61M | -36.05M | -39.75M | -26.86M | -33.21M | -32.48M | -36.65M | -45.25M | -51.98M | -53.73M |
Selling & General & Admin | 44.81M | 41.44M | 41.09M | 38.52M | 40.68M | 41.84M | 42.11M | 42.48M | 38.88M | 37.77M | 38.71M | 38.99M | 38.86M | 38.47M | 34.8M | 33.52M | 30.38M |
Research & Development | 8.38M | 8.92M | 3.36M | 4.24M | 5.6M | 5.66M | 11.79M | 13.3M | 14.54M | 16M | 15.76M | 14.75M | 13.16M | 14.42M | 14.2M | 14.1M | 13.71M |
Other Expenses | 313K | 172K | -1.52M | -1.9M | -1.05M | -1.05M | 73K | 84K | 6K | 44K | 78K | 67K | 89K | 71K | 88K | 108K | 102K |
Operating Expenses | 53.51M | 50.53M | 48.41M | 46.33M | 50.61M | 51.83M | 53.9M | 55.78M | 53.42M | 53.77M | 54.48M | 53.74M | 52.01M | 52.89M | 48.99M | 47.62M | 44.09M |
Interest Expense | 252K | 247K | 247K | 247K | 192K | n/a | 29.2M | 29.22M | 29.22M | 29.22M | 13K | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | 18.35M | 17.87M | 18.22M | 15.83M | 16.22M | 16.45M | 15.38M | 16.43M | 15.01M | 14.33M | 15.44M | 15.3M | 15.27M | 14.71M | 12.44M | 11.07M | 9.27M |
Cost & Expenses | 71.91M | 67.92M | 57.94M | 55.77M | 62.12M | 65.11M | 69.19M | 71.67M | 68.86M | 69.6M | 69.83M | 68.27M | 65.97M | 65.45M | 59.7M | 56.74M | 52.74M |
Income Tax Expense | 1.19M | 1.19M | 1.03M | 95K | 96K | 148K | 2.21M | 880K | 879K | 2.13M | 965K | 2.12M | 2.12M | 812K | -601K | -601K | -601K |
Shares Outstanding (Basic) | 15.49M | 15.49M | 15.29M | 13.52M | 13.38M | 13.38M | 13.38M | 13.34M | 13.34M | 13.46M | 13.61M | 13.61M | 13.8M | 13.8M | 13.98M | 13.89M | 12.48M |
Shares Outstanding (Diluted) | 15.49M | 15.49M | 15.29M | 13.52M | 13.38M | 13.38M | 13.38M | 13.34M | 13.34M | 13.46M | 13.61M | 13.61M | 13.8M | 13.8M | 13.98M | 13.98M | 12.48M |
EPS (Basic) | -2.7 | -2.72 | -2.23 | -2.03 | -2.28 | -2.02 | -3.02 | -3.05 | -2.84 | -3.01 | -1.97 | -2.32 | -2.26 | -2.75 | -3.55 | -4.26 | -4.62 |
EPS (Diluted) | -2.7 | -2.72 | -2.23 | -2.03 | -2.28 | -2.02 | -3.02 | -3.05 | -2.84 | -3.01 | -1.97 | -2.32 | -2.26 | -2.75 | -3.55 | -4.26 | -4.62 |
EBITDA | -41.16M | -38.89M | -31.07M | -27.63M | -24.15M | -22.53M | -24.22M | -25.16M | -23.88M | -24.07M | -30.75M | -31.63M | -30.68M | -33.4M | -32.06M | -32.94M | -33.32M |
EBIT | -38.53M | -37.2M | -30.32M | -27.48M | -27.23M | -25.28M | -26.92M | -28.03M | -26.47M | -26.49M | -32.83M | -33.36M | -32.54M | -35.35M | -33.94M | -34.84M | -35.27M |
Depreciation & Amortization | -3.01M | -2.08M | -1.14M | -915K | 3.08M | 2.75M | 2.71M | 3.11M | 3.18M | 3.31M | 3.08M | 2.84M | 2.97M | 3.1M | 3.21M | 3.23M | 2.94M |